Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030.The manufacturing hub will produce Roche’s continuous glucose monitoring (CGM) systems for diabetes management.
The center will include…
Respiree, Roche announces AI integration for RPMSingaporean startup Respiree has tied up with global pharmaceutical and diagnostics company Roche for technology integration.
Respiree will be combining its vital sign monitoring device with Roche’s blood glucose…
Calcification has significant influence over cardiovascular diseases and interventions. Detailed characterization of calcification is thus desired for predictive modeling, but calcium deposits on cardiovascular structures are still often manually reconstructed for physics-driven simulations. This…
Continue Reading
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
The first patient in England has been treated with a personalised vaccine against bowel cancer, in a clinical trial as part of NHS England’s Cancer Vaccine Launch Pad.The launch pad, created in partnership with…
Continue Reading
Oncology-focused digital health company Flatiron Health, which Roche acquired in a $1.9 billion deal in 2018, is announcing a strategic collaboration with the Association of Cancer Care Centers (ACCC) to promote access to clinical…
Continue Reading
– Enable Injections, Inc. (“Enable”), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche.
– The collaboration leverages Enable’s expertise in the enFuse® platform to accelerate the development and commercialization…
Continue Reading
Roche has developed a continuous glucose monitor with predictive algorithms that gives patients with diabetes a way of managing their condition and reducing uncertainty, with a potentially powerful impact on their quality of life. Roche…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
